The focus of this course is coagulopathies. In general, the term coagulopathy refers to bleeding disorders. This course will provide a review of the components of a clot. It will also provide you with valuable information about how to care for those with coagulopathies such as immune thrombocytopenia (ITP), disseminated intravascular coagulopathy (DIC), heparin-induced thrombocytopenia (HIT), and warfarin-induced coagulopathy.

The goal of this course is to provide nurses in the critical care setting with a general overview of coagulopathies, including the recognition and nursing management of ITP, DIC, HIT, and warfarin-induced coagulopathy. 

Heart failure (HF) treatment is costly and requires a multidisciplinary approach. Evidence-based treatment guidelines improve patient outcomes, and it is essential to become familiar with these guidelines to reduce patient mortality. Healthcare team members play a significant role in treating acute HF (AHF), helping to reduce the morbidity and mortality of the disease and decrease the use and costs associated with care. This course aims to educate nurses and nutrition and dietetics professionals in the acute care setting about evidence-based heart failure treatment guidelines.

By understanding the causes of stroke and how to treat and prevent it, you can make a significant difference in the lives of those you care for. This course will help you identify the symptoms of a stroke and provide you with the necessary knowledge to provide care during and after the stroke.
 

Bowel ischemia, infarctions, perforations, and obstructions are serious conditions that require prompt recognition and interventions to prevent severe complications and death. There are several underlying conditions that predispose patients to these conditions, for which education and risk modifications are crucial. 

The goal of this course is to equip nursing professionals in acute care with knowledge of risk factors, signs and symptoms, and management strategies for bowel ischemia, infarction, perforation, and obstruction.

It is estimated that there are more than 2.8 million people worldwide living with multiple sclerosis (MS). In the United States, there are almost 1 million people living with the disease (National Multiple Sclerosis Society [NMSS], 2020). MS is a chronic, progressive autoimmune disease of the central nervous system (CNS) caused by damage to the protective myelin sheath covering neurons. MS lesions, or plaques, disrupt electrical impulses from neurons in the CNS to muscles that can affect mobility, elimination, energy, vision, and other functions (DynaMed, 2022). 

This course provides a comprehensive understanding of stroke care from onset to rehab. Details of stroke care in the acute care setting and rehabilitation for stroke are reviewed. Stroke prevention strategies are explained. 

The goal of this course is to provide the clinician with up-to-date best practices for identifying and treating patients with PAD. It includes symptoms, complications, risk factors, and modifications of PAD. In addition, diagnostic tests, assessment, and treatment strategies will be discussed.

In this course, you will learn to identify different depressive disorders, as well as the unique ways depression manifests in children and adolescents. Additionally, you will learn to recognize risk factors for both depression and suicidality in youth.  

An integrated care model treats the whole child by combining primary care and mental healthcare in one setting. Within this model, treatment providers understand how to screen for depression and suicidality in order to coordinate care. You will learn about specific instruments useful for detecting depression and suicidality among youth. An understanding of the root causes of depression will highlight the rationale for various treatment approaches. Lastly, you will be able to describe the best practices available to help children and adolescents manage depression.  

When lifestyle modifications such as improving nutrition and increasing physical activity do not achieve adequate weight loss, pharmacotherapies may be needed. Pharmacotherapy is used as a supplement to lifestyle modifications and should only be implemented in patients who meet certain criteria and have a need to reduce their risk of obesity-related comorbidities. This course will review candidate criteria for weight management drugs, which drugs have been approved by the Food and Drug Administration (FDA), and their safety or effectiveness. It will also review dietary supplements used for weight loss and the lifestyle behaviors needed to increase the efficacy of pharmacotherapies. The goal of this course is to educate the healthcare team in the acute care setting on weight loss medications.